Apollomics, Inc. (APLM)
NASDAQ: APLM · Real-Time Price · USD
17.50
+3.54 (25.34%)
At close: Jun 18, 2026, 4:00 PM EDT
16.33
-1.17 (-6.68%)
After-hours: Jun 18, 2026, 7:49 PM EDT
Apollomics Market Cap
Apollomics has a market cap or net worth of $38.43 million as of June 18, 2026. Its market cap has increased by 428.49% in one year.
Market Cap
38.43M
Enterprise Value
35.79M
1-Year Change
428.49%
Ranking
Category
Stock Price
$17.50
Market Cap Chart
Since November 26, 2021, Apollomics's market cap has decreased from $129.59M to $38.43M, a decrease of -70.35%. That is a compound annual growth rate of -23.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 38.43M | -4.23% |
| Dec 31, 2025 | 40.12M | 273.20% |
| Dec 31, 2024 | 10.75M | -87.56% |
| Dec 29, 2023 | 86.40M | -37.89% |
| Dec 30, 2022 | 139.11M | 7.02% |
| Dec 30, 2021 | 129.98M | 0.30% |
| Nov 26, 2021 | 129.59M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lisata Therapeutics | 32.05M |
| Actinium Pharmaceuticals | 32.00M |
| Boundless Bio | 31.45M |
| Lite Strategy | 31.28M |
| Daré Bioscience | 31.16M |
| Dyadic International | 30.92M |
| NanoViricides | 30.53M |
| Plus Therapeutics | 29.67M |